Annual Total Long Term Liabilities
$639.57 M
-$518.41 M-44.77%
31 December 2022
Summary:
NuVasive annual total long term liabilities is currently $639.57 million, with the most recent change of -$518.41 million (-44.77%) on 31 December 2022. During the last 3 years, it has fallen by -$518.41 million (-44.77%).NUVA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$614.43 M
-$4.25 M-0.69%
30 June 2023
Summary:
NuVasive quarterly total long term liabilities is currently $614.43 million, with the most recent change of -$4.25 million (-0.69%) on 30 June 2023.NUVA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUVA Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -44.8% | -46.9% |
5 y5 years | -16.2% | -19.5% |
NUVA Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -44.8% | -46.9% |
NuVasive Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
June 2023 | - | $614.43 M(-0.7%) |
Mar 2023 | - | $618.68 M(-3.3%) |
Dec 2022 | $639.57 M(-44.8%) | $639.57 M(-0.9%) |
Sept 2022 | - | $645.39 M(-0.1%) |
June 2022 | - | $646.26 M(-41.2%) |
Mar 2022 | - | $1.10 B(-5.0%) |
Dec 2021 | $1.16 B(+23.5%) | $1.16 B(+3.9%) |
Sept 2021 | - | $1.11 B(+0.2%) |
June 2021 | - | $1.11 B(+0.7%) |
Mar 2021 | - | $1.10 B(+17.8%) |
Dec 2020 | $937.80 M(+22.9%) | $937.80 M(+0.1%) |
Sept 2020 | - | $936.56 M(-2.6%) |
June 2020 | - | $961.64 M(+74.2%) |
Mar 2020 | - | $552.19 M(-27.6%) |
Dec 2019 | $763.17 M(+10.0%) | $763.17 M(-0.9%) |
Sept 2019 | - | $770.12 M(+1.6%) |
June 2019 | - | $757.95 M(+1.2%) |
Mar 2019 | - | $749.32 M(+8.0%) |
Dec 2018 | $693.87 M(+2.1%) | $693.87 M(-1.4%) |
Sept 2018 | - | $703.54 M(+2.4%) |
June 2018 | - | $687.17 M(+1.4%) |
Mar 2018 | - | $677.47 M(-0.3%) |
Dec 2017 | $679.33 M(+8.2%) | $679.33 M(-0.5%) |
Sept 2017 | - | $683.07 M(+7.4%) |
June 2017 | - | $635.95 M(-0.2%) |
Mar 2017 | - | $637.10 M(+1.5%) |
Dec 2016 | $627.78 M(+29.7%) | $627.78 M(-0.8%) |
Sept 2016 | - | $632.83 M(+6.1%) |
June 2016 | - | $596.32 M(-24.5%) |
Mar 2016 | - | $789.37 M(+63.0%) |
Dec 2015 | $484.21 M(+1.1%) | $484.21 M(+0.7%) |
Sept 2015 | - | $480.96 M(+0.6%) |
June 2015 | - | $477.96 M(-7.8%) |
Mar 2015 | - | $518.17 M(+8.2%) |
Dec 2014 | $479.12 M(+4.7%) | $479.12 M(+2.4%) |
Sept 2014 | - | $467.73 M(+0.2%) |
June 2014 | - | $466.62 M(+0.6%) |
Mar 2014 | - | $463.81 M(+1.4%) |
Dec 2013 | $457.54 M | $457.54 M(+0.7%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2013 | - | $454.18 M(+0.8%) |
June 2013 | - | $450.77 M(-1.4%) |
Mar 2013 | - | $457.35 M(-1.0%) |
Dec 2012 | $461.94 M(+9.4%) | $461.94 M(+2.6%) |
Sept 2012 | - | $450.10 M(+1.0%) |
June 2012 | - | $445.66 M(+30.5%) |
Mar 2012 | - | $341.44 M(-19.1%) |
Dec 2011 | $422.14 M(+71.0%) | $422.14 M(-5.1%) |
Sept 2011 | - | $444.75 M(-31.5%) |
June 2011 | - | $648.95 M(+163.0%) |
Mar 2011 | - | $246.75 M(-0.0%) |
Dec 2010 | $246.82 M(-14.4%) | $246.82 M(-15.1%) |
Sept 2010 | - | $290.74 M(+0.7%) |
June 2010 | - | $288.69 M(-0.2%) |
Mar 2010 | - | $289.20 M(+0.3%) |
Dec 2009 | $288.22 M(+13.3%) | $288.22 M(-0.4%) |
Sept 2009 | - | $289.42 M(-0.2%) |
June 2009 | - | $289.96 M(+17.6%) |
Mar 2009 | - | $246.55 M(-3.0%) |
Dec 2008 | $254.29 M(>+9900.0%) | $254.29 M(-1.1%) |
Sept 2008 | - | $257.23 M(+11.6%) |
June 2008 | - | $230.59 M(-0.2%) |
Mar 2008 | - | $230.99 M(>+9900.0%) |
Dec 2007 | $1.12 M(-20.0%) | $1.12 M(+0.4%) |
Sept 2007 | - | $1.11 M(+0.3%) |
June 2007 | - | $1.11 M(-21.1%) |
Mar 2007 | - | $1.41 M(+0.7%) |
Dec 2006 | $1.40 M(-16.0%) | $1.40 M(+0.5%) |
Sept 2006 | - | $1.39 M(+0.5%) |
June 2006 | - | $1.39 M(-17.4%) |
Mar 2006 | - | $1.68 M(+0.7%) |
Dec 2005 | $1.67 M(>+9900.0%) | $1.67 M(+0.3%) |
Sept 2005 | - | $1.66 M(-2.0%) |
June 2005 | - | $1.69 M(>+9900.0%) |
Mar 2005 | - | $12.00 K(-7.7%) |
Dec 2004 | $13.00 K(-98.9%) | $13.00 K(-99.3%) |
Mar 2004 | - | $1.76 M |
Dec 2003 | $1.22 M(+272.0%) | - |
Dec 2002 | $329.00 K | - |
FAQ
- What is NuVasive annual total long term liabilities?
- What is the all time high annual total long term liabilities for NuVasive?
- What is NuVasive quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for NuVasive?
What is NuVasive annual total long term liabilities?
The current annual total long term liabilities of NUVA is $639.57 M
What is the all time high annual total long term liabilities for NuVasive?
NuVasive all-time high annual total long term liabilities is $1.16 B
What is NuVasive quarterly total long term liabilities?
The current quarterly long term liabilities of NUVA is $614.43 M
What is the all time high quarterly long term liabilities for NuVasive?
NuVasive all-time high quarterly total long term liabilities is $1.16 B